Skip to main content

Epigenetics | Growing Applications of Epigenetics in Personalized Medicine and Targeted Therapy & Use of It in Non-Oncology Applications To Boost The Market

The report “Epigenetics Market by Product (Kit, Enzymes, Reagent, NGS, Mass Spectrometer, PCR, Bioinformatics), Application (Oncology, Cardiology, Immunology), Technology (DNA Methylation, Histone Modification), End User (Academic, CRO) – Global Forecast to 2022″, The global epigenetics market is projected to reach USD 1,605.7 Million by 2022 from an estimated USD 854.0 Million in 2017, at a CAGR of 13.5% during the forecast period. The decreasing sequencing costs and time, increase in research activities to identify and develop inhibitors/drugs for various diseases, funding for epigenetics research, and rising prevalence of cancer are the major factors driving the growth of this market.

Browse 191 market tables and 37 figures spread through 230 pages and in-depth TOC on “Epigenetics Market by Product (Kit, Enzymes, Reagent, NGS, Mass Spectrometer, PCR, Bioinformatics), Application (Oncology, Cardiology, Immunology), Technology (DNA Methylation, Histone Modification), End User (Academic, CRO) – Global Forecast to 2022”
http://www.marketsandmarkets.com/Market-Reports/epigenetics-technologies-market-896.html
Early buyers will receive 10% customization on reports.

Kits Segment Accounted for the Largest Share of the Global Market, by Product
On the basis of product, the kits segment accounted for the largest share of the global epigenetics market in 2016. This can be attributed to the fact that a large number of kits are used in various epigenetic techniques. The rising prevalence of a number of diseases, increasing R&D spending, and increased government funding for life science research are the other factors expected to support market growth.

Among the Application Segments, Oncology Dominated the Global Epigenetics Market in 2016
Based on application, the oncology segment accounted for the largest share of the epigenetics market in 2016. The large share of this segment can be attributed to the rising prevalence of cancer and the increasing number of research-related activities.


DNA Methylation Segment Dominated the Epigenetics Market, by Technology in 2016
On the basis of technology, the epigenetics market is segmented into DNA methylation, histone modifications, and other technologies (includes non-coding RNA and chromatin remodeling). The DNA methylation segment accounted for the largest share of the global epigenetics market in 2016. The large share of this segment is attributed to the increasing incidence of cancer and the ability of this technique to study different types of cancer with quality outcomes.

North America Dominated the Global Epigenetics Market in 2016
North America accounted for the largest share of the epigenetics market in 2016, followed by Europe. Increase in epigenetics research activities, favorable government funding initiatives, high R&D expenditure, rising incidence of various diseases, and the presence of key players in the region are the key factors driving the growth of the epigenetics market in North America.


The major players in the global epigenetics market are Illumina (US), Thermo Fisher (US), Diagenode (Belgium), QIAGEN (US), Merck Millipore (US), Abcam (UK), Active Motif (US), New England Biolabs (US), Agilent (US), Zymo Research (US), PerkinElmer (US), and Bio-Rad (US).


About MarketsandMarkets™:

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “RT” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street,
Suite 2175, Seattle,
WA 98101, United States
1-888-600-6441
Email: sales@marketsandmarkets.com

Article Credit: Healthcare DC
Labels:

Comments

Post a Comment

Popular posts from this blog

A Best e-Commerce Platform for B2B & B2C Businesses – STORM

  Storm eCommerce platform is one of the modern, scalable, and advanced, eCommerce platforms, designed for online merchants who deal with several transactions. Smaller online retailers with rapidly growing business may also choose this product. Developed in 2008, Storm Commerce has turned out to be a useful platform with eCommerce solutions. Storm Commerce is mainly equipped with B2B functionalities, automated technologies, and user-friendly interface. USP of This Platform: Storm eCommerce platform is a seamless platform and its customized solutions can manage several deals of B2B and B2C businesses. The automation technologies have helped businesses to ensure an increased profitability, higher performance, and smarter workflows. As one of the cloud SaaS solutions, Storm is valuable for its performance and high capacity. The open APIs of Storm enable users to integrate a CMS and different other systems. It helps in developing omni-channel commerce with its features and functionalit...
1 comment
Read more

Cell Sorting Market

The global  cell sorting market  is projected to reach USD 247.4 Million by 2021, at a CAGR of 7.0% in the forecast period (2016-2021). Factors such as technological advancements in cell sorters, rising funding and investments for development of technologically advanced cell sorters, and growing adoption of cell sorting techniques in research activities are driving the growth of global Market. The market is further driven by factors such as the growing prevalence of HIV/AIDS and cancer, expanding pharmaceutical and biotechnology industries, and launch of specific reagents for specific applications. However, factors such as the high cost of instruments and lack of awareness & technical knowledge regarding the use of cell sorters are hampering the growth of market. Geographically, the market is segmented into North America, Europe, Asia-Pacific, and RoW. Among the four geographic regions, North America is estimated to command the largest share of the market in 2016, foll...
Post a Comment
Read more

Diagnostic Catheter Market: What Will be the Growth Scenario in the next five years?

 The overall diagnostic catheters market is projected to reach USD 4,302.3 million by 2021 from USD 3,025.8 million in 2016, at a CAGR of 7.3% from 2016 to 2021. Advancements in medical imaging technologies, increasing number of minimally invasive procedures, launch of new technologies in terms of catheter design, and rising geriatric population (resulting in a subsequent growth in the prevalence of chronic disorders) are primarily expected to drive growth in the global market. However, factors such as dearth of skilled professionals, high cost of technologically advanced catheters, and the trend of reusing single-use diagnostic catheters are expected to restrain market growth to a certain extent. Growing preference of OCT imaging catheters in intravascular diagnostics and imaging: OCT has revolutionized the medical imaging industry and has extended its applications in disease diagnosis and imaging of various cellular and molecular processes in vivo. The success...
Post a Comment
Read more